452 results on '"Johnson, Simon R."'
Search Results
2. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation
3. Lymphangioleiomyomatosis
4. Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis
5. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant
6. Mechanisms of Lung Cyst Formation
7. Genetic burden of dysregulated cytoskeletal organisation in the pathogenesis of pulmonary fibrosis
8. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management
9. Deep Learning–based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis.
10. Lymphangioleiomyomatosis: No Longer Ultra-rare
11. Diagnosis of cystic lung diseases: a position statement from the UK Cystic Lung Disease Rare Disease Collaborative Network
12. Residual Lung Abnormality Following COVID-19 Hospitalisation is Characterised by Epithelial Injury
13. Competing Causes of Death in Idiopathic Pulmonary Fibrosis.
14. Mechanisms of Lung Cyst Formation
15. Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
16. Lymphangioleiomyomatosis
17. A theoretical model of inflammation- and mechanotransduction-driven asthmatic airway remodelling
18. The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE Study
19. Airway epithelial cell isolation techniques affect DNA methylation profiles with consequences for analysis of asthma related perturbations to DNA methylation
20. Supplementary Tables 1-3 from Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
21. Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study
22. Differential remodeling in small and large murine airways revealed by novel whole lung airway analysis
23. A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis
24. Air travel and incidence of pneumothorax in lymphangioleiomyomatosis
25. Study of breast cancer incidence in patients of lymphangioleiomyomatosis
26. Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline
27. Reply: The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps
28. COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
29. Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe
30. Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two national cohorts
31. Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysis
32. Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis
33. Cross talk between LAM cells and fibroblasts may influence alveolar epithelial cell behavior in lymphangioleiomyomatosis
34. Differential remodelling in small and large murine airways revealed by novel whole lung airway analysis
35. Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodelling
36. Untangling the protease web in COPD: metalloproteinases in the silent zone
37. Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two national cohorts.
38. Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
39. A lung targeted miR-29 Mimic as a Therapy for Pulmonary Fibrosis
40. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
41. A 4-year prospective evaluation of protocols to improve clinical outcomes for patients with lymphangioleiomyomatosis in a national clinical centre
42. Tissue and matrix influences on airway smooth muscle function
43. Lymphangioleiomyomatosis
44. Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis
45. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
46. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
47. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
48. Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells
49. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study
50. Use of a three-dimensional cell culture model to study airway smooth muscle-mast cell interactions in airway remodeling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.